Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
Open Access
- 1 January 1997
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 349 (9044) , 20-22
- https://doi.org/10.1016/s0140-6736(96)02266-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)The Journal of Infectious Diseases, 1995
- Liver transplantation for hepatitis B virus—associated cirrhosis: A progress reportHepatology, 1994
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993
- Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.Proceedings of the National Academy of Sciences, 1993
- Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosidesAntimicrobial Agents and Chemotherapy, 1993
- High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assayAntimicrobial Agents and Chemotherapy, 1993
- Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.Proceedings of the National Academy of Sciences, 1991
- Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitisHepatology, 1991
- Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.Proceedings of the National Academy of Sciences, 1989